A Novel Therapeutic Target in Neurodegeneration

Mon Jan 14, 2019
ClotildeLagier-Tourenne MD, PhD, Assistant Professor of Neurology, discusses the findings in her paper, 'Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration' recently published in Nature Neuroscience.